Susquehanna International Securities, Ltd. Bio N Tech Se Transaction History

Susquehanna International Securities, Ltd.

  • $389 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
BUY
$126.25 - $231.85 $176,750 - $324,590
1,400 New
1,400 $237,000
Q4 2021

Feb 14, 2022
SELL
$216.64 - $362.52 $306,978 - $513,690
-1,417 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$205.93 - $447.23 $291,802 - $633,724
1,417 New
1,417 $387,000

Others Institutions Holding BNTX

# of Institutions
357
Shares Held
38.3M
Call Options Held
2.45M
Put Options Held
2.29M
View Full List

About BioNTech SE

BNTX Quotes by TradingView
  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $29.3B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Susquehanna International Securities, Ltd. Portfolio

Follow Susquehanna International Securities, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Securities, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Securities, Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email